The gene therapies AMT-060 and AMT-061 both restored coagulation factor IX levels in a primate model of hemophilia B, but…
Articles by Marisa Wexler, MS
Problematic thrombotic events are fairly rare in people using NovoSeven, among all types of bleeding disorders for which it is…
New data from clinical studies suggests that long-term preventive treatment of severe hemophilia A with Eloctate, or severe hemophilia…
Health Canada has approved Esperoct, an engineered formulation of clotting factor VIII, for the treatment of hemophilia…
Health Canada has approved Hemlibra (emicizumab) for people with Hemophilia A without factor VIII inhibitors. Hemlibra is an antibody…
Catalyst Biosciences announced the beginning of enrollment for a Phase 2b clinical trial for dalcinonacog alfa (DalcA) in people with…